103 related articles for article (PubMed ID: 9124449)
1. In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.
Barra JG; Levenson J; Armentano RL; Cabrera Fischer EI; Pichel RH; Simon A
Am J Physiol; 1997 Feb; 272(2 Pt 2):H859-68. PubMed ID: 9124449
[TBL] [Abstract][Full Text] [Related]
2. Preventive effect of chronic converting enzyme inhibition on aortic stiffening induced by renovascular hypertension in conscious dogs.
Fischer EI; Levenson J; Barra JG; Armentano RL; Pichel RH; Simon A
Cardiovasc Res; 1993 Jun; 27(6):1039-44. PubMed ID: 8221761
[TBL] [Abstract][Full Text] [Related]
3. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
Foucart S; Patrick SK; Oster L; de Champlain J
Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
[TBL] [Abstract][Full Text] [Related]
5. Effect of captopril and losartan on blood pressure and accumulation of LDL and fibrinogen by aortic wall and other tissues in normotensive and hypertensive rats.
Medina R; Cardona-Sanclemente LE; Born GV; Brown MJ
J Cardiovasc Pharmacol; 1997 Jan; 29(1):125-9. PubMed ID: 9007681
[TBL] [Abstract][Full Text] [Related]
6. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
[TBL] [Abstract][Full Text] [Related]
7. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
Richard V; Berdeaux A; Giudicelli JF
J Cardiovasc Pharmacol; 1993 Jul; 22(1):52-7. PubMed ID: 7690096
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
Marwood JF
Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.
Ryckwaert F; Colson P; André E; Perrigault PF; Guillon G; Barberis C
Br J Anaesth; 2002 Oct; 89(4):599-604. PubMed ID: 12393362
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
[TBL] [Abstract][Full Text] [Related]
12. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
[TBL] [Abstract][Full Text] [Related]
13. Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency.
Ishida Y; Tomori K; Nakamoto H; Imai H; Suzuki H
Adv Perit Dial; 2003; 19():10-4. PubMed ID: 14763026
[TBL] [Abstract][Full Text] [Related]
14. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
[TBL] [Abstract][Full Text] [Related]
15. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
Matrougui K; Lévy BI; Henrion D
Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
Richard V; Ghaleh B; Berdeaux A; Giudicelli JF
Br J Pharmacol; 1993 Nov; 110(3):969-74. PubMed ID: 8298820
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
O'Sullivan JB; Black MJ; Bertram JF; Bobik A
J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
